Abstract
Until recently, feline infectious peritonitis was an invariably fatal disease that occurs when a ubiquitous enteric coronavirus mutates. This enables it to replicate effectively within macrophages, resulting in immune-mediated phlebitis and serositis. While our understanding of the aetiopathogenesis of feline infectious peritonitis remains unchanged, with the recent availability of legalised antiviral drugs, successful treatment is now a possibility, albeit at a cost. As we approach a new dawn of research into the diagnosis and treatment of this disease, this review summarises current therapeutic options. Please note, some protocols are still being optimised.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
